LEMOORE, CALIFORNIA—“You should’ve been here yesterday.” That’s a repeated gag line in The Endless Summer, the classic 1966 documentary that follows two globetrotting surfers on a…
Comments closed
Category: Science
Eva Harris (far right) has led a dengue study in Nicaragua that for more than 12 years has regularly taken blood samples from children. Alejandro Belli/PLOS Pathogens
It’s a disease theory fit for a spy novel: Protective antibodies can turn double agent, teaming up with the dengue virus to make an infection…
Comments closed
Variations of the CRISPR DNA editor can change one DNA base into another. Shaury Nash/Flickr (CC BY SA 2.0)
Since the start of the CRISPR craze 5 years ago, scientists have raced to invent ever-more-versatile or efficient variations of this powerful tool, which vastly…
Comments closed
Dolutegravir HIV drug molecule.
For about $75, the governments in South Africa and Kenya will soon be able to treat an HIV-infected person for 1 year with a pill taken…
Comments closed
The influenza virus has yet to hit the Northern Hemisphere, but flu vaccine season is already in full swing, with banners outside pharmacies urging: “Get…
Comments closed
Surfing fin–embedded sensors collect coastal data. Kat Hammond
At 10:24:05 a.m. on 29 August, I entered the Pacific Ocean, surfboard in hand, at Swami’s, a break near my home in Cardiff, California. I…
Comments closed
Many countries recommend that pregnant women receive the flu vaccine. Patrick ALLARD/REA/Redux
News Staff Writer Jon Cohen wrote the 2005 book Coming to Term: Uncovering the Truth About Miscarriage, so ScienceInsider asked him for his perspective on one of…
Comments closed
Americans have conflicting views on how technologies that allow human genome editing, such as one that uses the Cas9 enzyme to snip DNA, should be employed. Meletios/shutterstock
CRISPR, the powerful genome-editing tool, does a molecular tango to cut and modify DNA that is highly nuanced. The same subtlety applies to the public’s…
Comments closed
The European Patent Office has signaled that it intends to grant MilliporeSigma a key CRISPR patent. vchal/shutterstock
MilliporeSigma, a subsidiary of pharmaceutical giant Merck KGaA of Darmstadt, Germany, has become a new major player in the complicated European patent battles over CRISPR,…
Comments closed